Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nishank Jain

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of the American Society of Nephrology : JASN|January 21, 2026
Fungal DNA in Circulation: A Sleuth's Clue to Predict Cardiovascular Risk for Hemodialysis PatientsNishank Jain, Parth Dhamelia, John M Arthur
Connecticut Medicine|October 7, 2008
An unusual case of headacheNishank Jain, Nitesh Sood, Peter Wade, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2024
Authors' Reply: Platelet Count, Platelet Volume and CKDRajshekhar Kore, Dharmik Jadvani, John M Arthur, et al.
Kidney Diseases (Basel, Switzerland)|August 19, 2016
Current Challenges in the Evaluation and Management of HyponatremiaKerri McGreal, Pooja Budhiraja, Nishank Jain, et al.
Kidney International Reports|June 20, 2024
Response to [Challenging the Restrictive Approach: Reconsidering SGLT-2 Inhibitor Use in CKD]Tushar Tarun, Otis M Davis, Sai N Ghanta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 13, 2025
Sepsis-Related Hospitalization and Mortality in Patients with CKDNinad Khandekar, Shung Chiu, Lauren Tong, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2014
Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKDGates Colbert, Nishank Jain, James A de Lemos, et al.
The American Journal of Cardiology|November 6, 2021
Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic DialysisNishank Jain, Milind A Phadnis, Bradley C Martin, et al.
Kidney360|July 21, 2025
Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKDNishank Jain, Lucas R Johnson, Dharmik Jadvani, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?Nishank Jain, S Susan Hedayati, Ravindra Sarode, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of the American Society of Nephrology : JASN|January 21, 2026
Fungal DNA in Circulation: A Sleuth's Clue to Predict Cardiovascular Risk for Hemodialysis PatientsNishank Jain, Parth Dhamelia, John M Arthur
Connecticut Medicine|October 7, 2008
An unusual case of headacheNishank Jain, Nitesh Sood, Peter Wade, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2024
Authors' Reply: Platelet Count, Platelet Volume and CKDRajshekhar Kore, Dharmik Jadvani, John M Arthur, et al.
Kidney Diseases (Basel, Switzerland)|August 19, 2016
Current Challenges in the Evaluation and Management of HyponatremiaKerri McGreal, Pooja Budhiraja, Nishank Jain, et al.
Kidney International Reports|June 20, 2024
Response to [Challenging the Restrictive Approach: Reconsidering SGLT-2 Inhibitor Use in CKD]Tushar Tarun, Otis M Davis, Sai N Ghanta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 13, 2025
Sepsis-Related Hospitalization and Mortality in Patients with CKDNinad Khandekar, Shung Chiu, Lauren Tong, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2014
Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKDGates Colbert, Nishank Jain, James A de Lemos, et al.
The American Journal of Cardiology|November 6, 2021
Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic DialysisNishank Jain, Milind A Phadnis, Bradley C Martin, et al.
Kidney360|July 21, 2025
Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKDNishank Jain, Lucas R Johnson, Dharmik Jadvani, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?Nishank Jain, S Susan Hedayati, Ravindra Sarode, et al.
Pageof 5